We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

2 hedge funds and large institutions have $49K invested in Meridian Bioscience Inc in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 212 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 218 → 2 (-216)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $1.32B → $49K (-$1.32B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 212

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-216
Holders Change %
-99.08%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
212
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$251M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$165M
3
MF
Magnetar Financial
Illinois
-$72.2M
4
Renaissance Technologies
Renaissance Technologies
New York
-$69.8M
5
NAM
Nexpoint Asset Management
Texas
-$64.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
51
Vazirani Asset Management
New York
– -$3.85M -115,774 Closed
AAM
52
Alpine Associates Management
Florida
– -$3.81M -114,800 Closed
Legal & General Group
53
Legal & General Group
United Kingdom
– -$3.59M -108,113 Closed
Swiss National Bank
54
Swiss National Bank
Switzerland
– -$3.51M -105,600 Closed
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
– -$3.22M -96,989 Closed
QC
56
Quantedge Capital
Singapore
– -$3.19M -96,000 Closed
New York State Teachers Retirement System (NYSTRS)
57
New York State Teachers Retirement System (NYSTRS)
New York
– -$2.86M -85,995 Closed
Wells Fargo
58
Wells Fargo
California
– -$2.77M -83,331 Closed
Public Sector Pension Investment Board (PSP Investments)
59
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$2.64M -79,590 Closed
WG
60
Winton Group
United Kingdom
– -$2.48M -74,675 Closed
Deutsche Bank
61
Deutsche Bank
Germany
– -$2.11M -63,388 Closed
American Century Companies
62
American Century Companies
Missouri
– -$2.1M -63,347 Closed
ETM
63
Euclidean Technologies Management
Washington
– -$2.09M -62,995 Closed
WAM
64
Wolverine Asset Management
Illinois
– -$2.05M -61,661 Closed
PCM
65
Prelude Capital Management
New York
– -$1.98M -59,592 Closed
ETC
66
Exchange Traded Concepts
Oklahoma
– -$1.86M -55,898 Closed
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
– -$1.83M -55,229 Closed
Citigroup
68
Citigroup
New York
– -$1.83M -54,974 Closed
Canada Life
69
Canada Life
Manitoba, Canada
– -$1.82M -54,697 Closed
FIA
70
FNY Investment Advisers
New York
– -$1.69M -51,000 Closed
BA
71
Bridgewater Associates
Connecticut
– -$1.69M -50,827 Closed
UBS Group
72
UBS Group
Switzerland
– -$1.69M -50,739 Closed
Barclays
73
Barclays
United Kingdom
– -$1.67M -50,293 Closed
Canada Pension Plan Investment Board
74
Canada Pension Plan Investment Board
Ontario, Canada
– -$1.6M -48,200 Closed
Prudential Financial
75
Prudential Financial
New Jersey
– -$1.57M -47,233 Closed
1 2
3
4 5

VIVO Hedge Fund Activity: Q1 2023 in Review

2 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2023, worth a combined $49K — down 100% from $1.32B a quarter earlier.

Sellers outnumbered buyers: 212 funds closed out of VIVO and 0 opened new positions — a net loss of 212 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $251M sold.

  • 2 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2023, down from 218 in Q4 2022.
  • Funds reported $49K of Meridian Bioscience Inc stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Meridian Bioscience Inc positions in Q1 2023 and 212 closed out, a net change of -212 holders.
  • The largest Meridian Bioscience Inc seller in Q1 2023 was BlackRock, an estimated $251M sold.

Based on aggregated 13F filings for Q1 2023.